AACR Special Conference in Cancer Research: RNAs as Drivers, Targets, and Therapeutics in Cancer
November 14-17, 2024
Hyatt Regency Bellevue on Seattle’s Eastside
Bellevue, Washington
conference cochairs
Howard Y. Chang, Stanford University, Stanford, California
Joshua T. Mendell, University of Texas Southwestern Medical Center, Dallas, Texas
Anastasia Khvorova, University of Massachusetts Chan Medical School, Worcester, Massachusetts
V. Narry Kim, Seoul National University, Seoul, Korea
The conference promises to be an illuminating gathering focused on RNAs as pivotal drivers, targets, and therapeutics in cancer. Plenary sessions will delve into cutting-edge research on identifying RNA drivers of cancer progression, targeting them for intervention, and leveraging RNA-based therapeutics and RNA vaccines, alongside discussions on computational methods for uncovering RNA-cancer connections. Engage in conversations about translating RNA-focused discoveries into clinical applications and personalized cancer treatments. Join leading researchers, clinicians, and industry experts for an insightful exchange of ideas and advancements at this transformative event shaping the future of cancer therapy.
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
